Related Experiment Video
Updated: Jun 15, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Fatty acid-genotype interactions and cardiovascular risk
1Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. a.m.minihane@reading.ac.uk
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|March 6, 2010
Summary
Understanding genetic and dietary interactions is key to cardiovascular disease (CVD) risk. Factors like ethnicity and gender influence these nutrigenetic effects, impacting personalized CVD prevention strategies.
Area of Science:
- Nutrigenetics and cardiovascular disease (CVD) research.
Background:
- Cardiovascular disease (CVD) risk is influenced by genetic, environmental, and behavioral factors.
- Current research often focuses on single nucleotide polymorphisms (SNPs) and dietary fat interactions affecting blood lipids, identifying hypo- and hyper-responders.
- A significant challenge in nutrigenetics is the inconsistency of findings across studies.
Purpose of the Study:
- To address the lack of consistency in nutrigenetics research.
- To investigate the influence of factors like ethnicity and gender on nutrigenetic interactions related to CVD.
- To highlight the potential of genetic profiling for future CVD prediction and personalized risk reduction.
Main Methods:
- Review of existing genotype-diet-CVD phenotype research.
- Analysis of factors contributing to inconsistencies in nutrigenetic study findings.
- Exploration of the role of ethnicity and gender in moderating nutrigenetic interactions.
Main Results:
- Inconsistencies in nutrigenetics research may be attributed to variations in ethnicity and gender.
- These demographic factors significantly impact the magnitude of nutrigenetic interactions.
- Understanding these influences is crucial for advancing the field.
Conclusions:
- Nutrigenetic interactions are complex and modulated by demographic factors.
- Further research is needed to elucidate the precise impact of ethnicity and gender on genotype-diet-CVD relationships.
- Genetic profiling holds promise for enhancing CVD prediction and enabling personalized prevention strategies in the future.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:28Overview of Fatty Acid Metabolism
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...